191 related articles for article (PubMed ID: 15861129)
1. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3.
Yoneda-Kato N; Tomoda K; Umehara M; Arata Y; Kato JY
EMBO J; 2005 May; 24(9):1739-49. PubMed ID: 15861129
[TBL] [Abstract][Full Text] [Related]
2. Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.
Yoneda-Kato N; Kato JY
Mol Cell Biol; 2008 Jan; 28(1):422-34. PubMed ID: 17967869
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein.
Yoneda-Kato N; Fukuhara S; Kato J
Oncogene; 1999 Jun; 18(25):3716-24. PubMed ID: 10391679
[TBL] [Abstract][Full Text] [Related]
5. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
[TBL] [Abstract][Full Text] [Related]
6. Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia.
Nakamae I; Kato JY; Yokoyama T; Ito H; Yoneda-Kato N
Blood Adv; 2017 Sep; 1(20):1682-1693. PubMed ID: 29296815
[TBL] [Abstract][Full Text] [Related]
7. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
Yoneda-Kato N; Look AT; Kirstein MN; Valentine MB; Raimondi SC; Cohen KJ; Carroll AJ; Morris SW
Oncogene; 1996 Jan; 12(2):265-75. PubMed ID: 8570204
[TBL] [Abstract][Full Text] [Related]
8. COP9 signalosome subunit 3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast.
Yan J; Walz K; Nakamura H; Carattini-Rivera S; Zhao Q; Vogel H; Wei N; Justice MJ; Bradley A; Lupski JR
Mol Cell Biol; 2003 Oct; 23(19):6798-808. PubMed ID: 12972600
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
[TBL] [Abstract][Full Text] [Related]
10. cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia.
Hitzler JK; Witte DP; Jenkins NA; Copeland NG; Gilbert DJ; Naeve CW; Look AT; Morris SW
Am J Pathol; 1999 Jul; 155(1):53-9. PubMed ID: 10393836
[TBL] [Abstract][Full Text] [Related]
11. Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome.
Matsumoto N; Yoneda-Kato N; Iguchi T; Kishimoto Y; Kyo T; Sawada H; Tatsumi E; Fukuhara S
Leukemia; 2000 Oct; 14(10):1757-65. PubMed ID: 11021751
[TBL] [Abstract][Full Text] [Related]
12. Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin.
Sanchez-Barcelo EJ; Mediavilla MD; Vriend J; Reiter RJ
J Pineal Res; 2016 Aug; 61(1):41-51. PubMed ID: 27121162
[TBL] [Abstract][Full Text] [Related]
13. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.
Matsuzawa S; Takayama S; Froesch BA; Zapata JM; Reed JC
EMBO J; 1998 May; 17(10):2736-47. PubMed ID: 9582267
[TBL] [Abstract][Full Text] [Related]
14. Myeloid leukemia factor-1 is a novel modulator of neonatal rat cardiomyocyte proliferation.
Rangrez AY; Pott J; Kluge A; Frauen R; Stiebeling K; Hoppe P; Sossalla S; Frey N; Frank D
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):634-644. PubMed ID: 28087342
[TBL] [Abstract][Full Text] [Related]
15. Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome.
Banda NK; Guthridge C; Sheppard D; Cairns KS; Muggli M; Bech-Otschir D; Dubiel W; Arend WP
J Immunol; 2005 Mar; 174(6):3608-16. PubMed ID: 15749898
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of full-length human myeloid leukemia factor 1 (MLF1) is independent of 14-3-3 proteins.
Molzan M; Ottmann C
Cell Mol Biol Lett; 2013 Mar; 18(1):137-48. PubMed ID: 23271436
[TBL] [Abstract][Full Text] [Related]
17. The myeloid leukemia factor interacts with COP9 signalosome subunit 3 in Drosophila melanogaster.
Sugano W; Ohno K; Yoneda-Kato N; Kato JY; Yamaguchi M
FEBS J; 2008 Feb; 275(3):588-600. PubMed ID: 18199288
[TBL] [Abstract][Full Text] [Related]
18. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway.
Ba MA; Surina J; Singer CA; Valencik ML
BMC Pharmacol Toxicol; 2017 Jun; 18(1):47. PubMed ID: 28623958
[TBL] [Abstract][Full Text] [Related]
20. Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia.
Arber DA; Chang KL; Lyda MH; Bedell V; Spielberger R; Slovak ML
Hum Pathol; 2003 Aug; 34(8):809-13. PubMed ID: 14506644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]